Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7685814 | 0.89 | NPY1R (0.69) | NPY1RTP53 | |
| SCHEMBL7688977 | 0.89 | NPY1R (0.69) | NPY1RTP53 | |
| SCHEMBL7688924 | 0.88 | NPY1R (0.68) | NPY1RTP53 | |
| SCHEMBL7689384 | 0.88 | NPY1R (0.68) | NPY1RTP53 | |
| SCHEMBL7962010 | 0.86 | NPY1R (0.77) | NPY1RTP53 | |
| SCHEMBL7689052 | 0.86 | NPY1R (0.66) | NPY1RTP53 | |
| SCHEMBL7684427 | 0.85 | NPY1R (0.78) | NPY1R | |
| SCHEMBL7686275 | 0.85 | NPY1R (0.79) | NPY1R | |
| SCHEMBL7691410 | 0.84 | NPY1R (0.85) | NPY1R | |
| SCHEMBL7693345 | 0.83 | NPY1R (0.62) | NPY1RTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020007071-A1 | Benzimidzolyl neuropeptide Y receptor antagonists | BRITTON THOMAS CHARLES (US) | 2002-01-17 | — | — | US | disclosed |
| US-6255494-B1 | SUBSTITUTED BENZIMIDAZOLES USEFUL IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH EXCESS OF NEUROPEPTIDE Y (AROUND ARTERIES IN HEART, RESPIRATORY TRACT, GASTROINTESTINAL TRACT AND GENITOURINARY TRACT); ETIOLOGY OF PSYCHIATRIC DISORDERS | ELI LILLY AND COMPANY | 2001-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007071-A1 | Benzimidzolyl neuropeptide Y receptor antagonists | NPY1R, NPY2R, NPY5R | NPY1R 1/4885TP53 4432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.